Method Development for the Separation of Therapeutic Proteins (Biopolymers)

Dec 11 2017 - Dec 12 2017

This course gives an extensive training on HPLC (UHPLC) method development for the separation of therapeutic proteins. The fundamentals of reversed-phase (RP), ion-exchange (IEX), hydrophobic interaction (HI) and size-exclusion (SE) chromatography are explained and discussed. Several examples on monoclonal antibodies (mAbs) and related products (such as antibody-drug conjugates /ADCs/) are presented. 

MAbs and related therapeutics currently account for global sales of ≥USD 50 billion and are starting to receive competition from biosimilar incomes. Most pharmaceutical companies have entered the rapidly growing biosimilar market. Therefore, the appropriate and detailed analysis of biopharmaceuticals at different levels (top-down, middle-down and bottom-up) is demanded by the authorities.

Participants will learn the different two- and three-dimensional (3D) optimization models for all the above mentioned chromatographic modes. Fast and efficient method adjustment, transfer and robustness testing are also demonstrated.



+49 30 421 5590
http://molnar-institute.com/services/#training-courses

Digital Edition

Labmate UK & Ireland July

July 2018

In This Edition Articles - Why Does Nanotechnology Require Mass Spectrometry Spotlight Features Luminescence, UV & Microplate Readers - New Confocal Laser Scanning Microscope Combine...

View all digital editions

Events

ACS National Meeting & Expo

Aug 19 2018 Boston, MA, USA

EuCheMS Chemistry Congress

Aug 26 2018 Liverpool, UK

DioXin 2018

Aug 26 2018 Krakow, Poland

IMSC 2018

Aug 26 2018 Florence, Italy

Medical Fair Asia 2018

Aug 29 2018 Singapore

View all events